About: Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article (publication date: 2001)

Attributes	Values
rdf:type	Item
description	artículu científicu espublizáu en 2001 (ast) vědecký článek publikovaný v roce 2001 (cs) مقالة علمية (نشرت عام 2001) (ar) наукова стаття, опублікована у 2001 (uk) 2001 թվականին հրատարակված գիտական հոդված (hy) 2001 թուականին հրատարակուած գիտական յօդուած (hyw) vedecký článok (publikovaný 2001) (sk) wetenschappelijk artikel (gepubliceerd in 2001) (nl) scientific article (publication date: 2001) (en) article scientifique publié en 2001 (fr) im Januar 2001 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q28188396-874157E3-4CD1-4BBB-9A23-7F41394E9700
publication date	2001-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q28188396-8D2CF952-23F2-4F2D-B375-162ADA22D8E7
language of work or name	English
exact match	wds:Q28188396-19E4D6E4-0AC0-440F-888C-B60E6D03984A
exact match	https://scigraph.springernature.com/pub.10.2165/00023210-200115080-00005
cites work	wds:Q28188396-070F5809-1ACC-4869-9F80-AA7A588A22B3 wds:Q28188396-0F3402A7-F270-4F6F-9512-78F562082EB5 wds:Q28188396-14A4AB47-0215-4164-9CE4-6AF06F9703CA wds:Q28188396-309AA34A-94BB-4762-9177-A2730D147CA8 wds:Q28188396-37CF1FC3-AE15-4338-85D4-E1F70FE0B2F9 wds:Q28188396-3C653E55-8758-4B2B-9766-99B0F553E2CB wds:Q28188396-3C9CDCB5-22AD-455C-8297-3B5BA696E212 wds:Q28188396-4DE8D1AC-7333-40D1-8D09-24863292EB3F wds:Q28188396-50ED1AFC-373E-4343-BE36-A7C4C3323F40 wds:Q28188396-6454CCB0-31C2-43E6-9216-360D1A6B4240 wds:Q28188396-665DCA0E-659A-4D02-8180-5F247B3E26D8 wds:Q28188396-69657A3D-C0EA-453F-9ABF-555BE33C6DC8 wds:Q28188396-738B77D9-42CC-4748-94E3-2E94B61A4B1B wds:Q28188396-A7436E10-2542-4553-9559-4FE9634F2ABB wds:Q28188396-A84AE8C4-FA24-402A-AE9B-CFBCAEFC2388 wds:Q28188396-ABEFCE94-1513-48C0-B8A5-B40BA77F6190 wds:Q28188396-B6E3E702-CA52-4594-A29C-F1C6F74181BB wds:Q28188396-B99000D1-A777-4276-9D82-0E73CFC41954 wds:Q28188396-DC061120-FA06-4080-8027-AF0F118C7022 wds:Q28188396-DD1F1DB9-CD91-4A43-8B08-C0B70053DC18 wds:Q28188396-E2822116-1801-4209-82A0-BF8441E4A8BF wds:Q28188396-E46B0B15-97F9-45C9-92FF-D9AF0613FD9D wds:Q28188396-EA22BEA0-07A9-4CB3-8221-CF97B9CD36C9 wds:Q28188396-EBD8C80D-27CA-4C6C-85EB-12E157EB54CC wds:Q28188396-EC4AC65F-180B-4F19-AA8C-91FE890BCDD6 wds:Q28188396-F731BB8A-0367-4925-8150-E1EB0B849E81 wds:Q28188396-FA4E4714-0721-4950-8F3C-5B93F70C2C09
cites work	Acute stroke with atrial fibrillation. The Copenhagen Stroke Study. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators Canadian atrial fibrillation anticoaguiation (CAFA) study Optimal oral anticoagulant therapy in patients with nonrheumatic atrial fibrillation and recent cerebral ischemia An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation : a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperat Stroke Prevention in Atrial Fibrillation Study. Final results Antithrombotic therapy in atrial fibrillation The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications Implications of Stroke Risk Criteria on the Anticoagulation Decision in Nonvalvular Atrial Fibrillation Atrial fibrillation and stroke. Three new studies, three remaining questions Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin: Stroke Prevention in Atrial Fibrillation III Study. The SPAF III Writing Committee for the Stroke Prevention in Atrial Fibrillation Investigators Prevention of stroke in patients with nonvalvular atrial fibrillation Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama Study Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Intensity of anticoagulation to prevent stroke in patients with atrial fibrillation Intracranial microembolic signals in 500 patients with potential cardiac or carotid embolic source and in normal controls. [Warfarin therapy for secondary prevention of cardioembolic stroke with nonvalvular atrial fibrillation--a retrospective study]
author name string	wds:Q28188396-485A4C56-5F80-4B7A-A67E-93FDD60CFA3C wds:Q28188396-607DBC7C-E98C-4786-8A73-FFCA5287EBB5
author name string	T Yamaguchi M Yasaka
rdfs:label	Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation (en) Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation (nl) Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation (ast)
skos:prefLabel	Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation (en) Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation (nl) Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation (ast)
name	Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation (en) Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation (nl) Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation (ast)
title	wds:Q28188396-21994452-3E22-4F8D-B1C0-FFE5E3ECCDA6
title	Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation (en)
page(s)	wds:Q28188396-1259FD84-8E60-4BCD-B9DC-5D263DFD20A9
page(s)	623-31
instance of	wds:Q28188396-2177bb22-a3ce-4bf4-ad1b-235012a19c0f wds:Q28188396-9B554CE6-756D-4CA3-9BE8-5BA67ECD4DEF
instance of	review article scholarly article
main subject	wds:Q28188396-6C4584A8-3536-4B5A-A065-7E5298358306 wds:Q28188396-B9CB112A-7654-4912-9510-B320F9031C1F
main subject	atrial fibrillation anticoagulation
PubMed ID	wds:Q28188396-D33374D0-351C-45FF-ABF6-359B0C0BDAA7
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11524034
PubMed ID	11524034

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software